Binding constants determined from Ca2+ current responses to rapid applications and washouts of nifedipine in frog cardiac myocytes

Journal of Physiology

Volumn 494, Issue 1, 1996, Pages 105-120

  Méry, Pierre François ^a   Hove Madsen, Leif ^a,b   Mazet, Jean Luc ^a   Hanf, Rémy ^a,c   Fischmeister, Rodolphe ^a  

^a INSERM   (France)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Innothera   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; MEMBRANE PROTEIN; NIFEDIPINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM CURRENT; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG PROTEIN BINDING; EQUILIBRIUM CONSTANT; FROG; HEART MUSCLE CELL; MEMBRANE DEPOLARIZATION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL;

EID: 0029969945     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.1996.sp021479     Document Type: Article

References (40)

1. BEAN, B. P. (1984). Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proceedings of the National Academy of Sciences of the USA 81, 6388-6392.
2. BECHEM, M. & HOFFMANN, H. (1993). The molecular mode of action of the Ca agonist (-)BAY K-8644 on the cardiac Ca channel. Pflügers Archiv 424, 343-353.
3. BROWN, A. M., KUNZE, D. L. & YATANI, A. (1986). Dual effects of dihydropyridines on whole cell and unitary calcium currents in single ventricular cells of guinea-pig. Journal of Physiology 379, 495-514.
4. 2+ channel antagonists. Trends in Pharmacological Sciences 13, 256-262.
5. 2+ channel activator (Bay K 8644) and inhibitor (PN 200-110). Proceedings of the National Academy of Sciences of the USA 83, 1518-1522.
6. FISCHMEISTER, R. & HARTZELL, H. C. (1986). Mechanism of action of acetylcholine on calcium current in single cells from frog ventricle. Journal of Physiology 376, 183-202.
7. GURNEY, A. M., NERBONNE, J. M. & LESTER, H. A. (1985). Photoinduced removal of nifedipine reveals mechanisms of calcium antagonist action on single heart cells. Journal of General Physiology 86, 353-379.
8. HAMILTON, S. L., YATANI, A., BRUSH, K., SCHWARTZ, A. & BROWN, A. M. (1987). A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes. Molecular Pharmacology 31, 221-231.
9. HERBETTE, L. G., RHODES, D. G. & MASON, R. P. (1991). New-approaches to drug design and delivery based on drug-membrane interactions. Drug Design and Delivery 7, 75-118.
10. HERBETTE, L. G., VANTERVE, Y. M. H. & RHODES, D. G. (1989). Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes - Lipid bilayer partitioning could occur before drug binding to receptors. Journal of Molecular and Cellular Cardiology 21, 187-201.
11. HERING, S., BEECH, D. J., BOLTON, T. B. & LIM, S. P. (1988). Action of nifedipine or Bay K8644 is dependent on calcium channel state in single smooth muscle cells from rabbit ear artery. Pflügers Archiv 411, 590-592.
12. HERING, S., HUGHES, A. D., TIMIN, E. N. & BOLTON, T. B. (1993). Modulation of calcium channels in arterial smooth muscle cells by dihydropyridine enantiomers. Journal of General Physiology 101, 393-410.
13. HERING, S. & TIMIN, E. N. (1993). Estimation of drug affinities for calcium channel conformational states. Methods in Pharmacology 7, 189-219.
14. HERZIG, S., LULLMAN, H. & SIEG, H. (1992). Frequency- and potential-dependency of the negative inotropic action of various dihydropyridine and non-dihydropyridine calcium antagonists. Pharmacology and Toxicology 71, 229-235.
15. HUGHES, A. D. & WIJETUNGE, S. (1993). The action of amlodipine on voltage-operated calcium channels in vascular smooth muscle. British Journal of Pharmacology 109, 120-125.
16. KALASZ, H., WATANABE, T., YABANA, H., ITAGAKI, K., NAITO, K., NAKAYAMA, H., SCHWARTZ, A. & VAGHY, P. L. (1993). Identification of 1,4-dihydropyridine binding domains within the primary structure of the alpha-1 subunit of the skeletal muscle L-type calcium channel. FEBS Letters 331, 177-181.
17. KASS, R. S., ARENA, J. P. & CHIN, S. (1991). Block of L-type calcium channels by charged dihydropyridines: sensitivity to side of application and calcium. Journal of General Physiology 98, 63-75.
18. KOHLHARDT, M. & FLECKENSTEIN, A. (1977). Inhibition of the slow inward current by nifedipine in mammalian ventricular myocardium. Naunyn-Schmiedeberg's Archives of Pharmacology 298, 267-272.
19. KOKUBUN, S., PROD'HOM, B., BECKER, C., PORZIG, H. & REUTER, H. (1986). Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers. Molecular Pharmacology 30, 571-584.
20. KUNZE, D. L., HAMILTON, S. L., HAWKES, M. J. &. BROWN, A. M. (1987). Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells. Molecular Pharmacology 31, 401-409.
21. LEE, K. S. & TSIEN, R. W. (1983). Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature 302, 790-794.
22. LEE, R. T., SMITH, T. W. &. MARSH, J. D. (1987). Evidence for distinct calcium channel agonist and antagonist binding sites in intact cultured embryonic chick ventricular cells. Circulation Research 60, 683-691.
23. 2+ channels in clonal rat pituitary cells by membrane depolarisation. Molecular Pharmacology 45, 1198-1206.
24. MARSH, J. D., LOH, E., LACHANCE, D., BARRY, W. H. & SMITH, T. W. (1983). Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells. Circulation Research 53, 539-543.
25. MASON, R. P., CAMPBELL, S. F., WANG, S. D. & HERBETTE, L. G. (1989). Comparison of location and binding for the positively charged 1,4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes. Molecular Pharmacology 36, 634-640.
26. MÉRY, P.-F., HOVE-MADSEN, L., HANF, R. & FISCHMEISTER, R. (1994). Binding constants determined from calcium current responses to rapid applications and washouts of nifedipine in frog cardiac myocytes. Journal of Physiology 477, P87-88P.
27. MÉRY, P.-F., LECHÊNE, P. & FISCHMEISTER, R. (1992). A loudspeaker-driven system for rapid and multiple solution exchanges in patch-clamp experiments. Pflügers Archiv 420, 529-535.
28. MIRONNEAU, J., YAMAMOTO, T., SAYET, I., ARNAUDEAU, S., RAKOTOARISOA, L. & MIRONNEAU, C. (1992). Effect of dihydropyridines on calcium channels in isolated smooth muscle cells from rat vena cava. British Journal of Pharmacology 105, 321-328.
29. MIWA, K., MIYAGI, Y., ARAIE, E. & SASAYAMA, S. (1992). Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes. European Journal of Pharmacology 214, 127-132.
30. PORZIG, H. (1990). Pharmacological modulation of voltage-dependent calcium channels in intact cells. Review of Physiology, Biochemistry and Pharmacology 114, 209-262.
31. SALOMONE, S. & GODFRAIND, T. (1993). Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle. British Journal of Pharmacology 109, 100-106.
32. SANGUINETTI, M. C. & KASS, R. S. (1984). Voltage-dependent block of calcium channel current in the calf cardiac fiber by dihydropyridine calcium channel antagonists. Circulation Research 55, 336-348.
33. SARMIENTO, J. G., JANIS, R. A., COLVIN, R. A., TRIGGLE, D. J. & KATZ, A. M. (1983). Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle. Journals of Molecular and Cellular Cardiology 15, 135-137.
34. STRUBING, C., HERING, S. & GLOSSMANN, H. (1993). Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels. British Journal of Pharmacology 108, 884-891.
35. TANG, S. Q., YATANI, A., BAHINSKI, A., MORI, Y. & SCHWARTZ, A. (1993). Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action. Neuron 11, 1013-1021.
36. UEHARA, A. & HUME, J. R. (1985). Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cells. Journal of General Physiology 85, 621-647.
37. 2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes. Molecular Pharmacology 35, 541-552.
38. WELLING, A., KWAN, Y. W., BOSSE, E., FLOCKERZI, V., HOFMANN, F. & KASS, R. S. (1993). Subunit-dependent modulation of recombinant L-type calcium channels - Molecular basis for dihydropyridine tissue selectivity. Circulation Research 73, 974-980
39. 3H]isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxy- carbonyl-2,6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINmSF membranes and cells - characterization and functional significance. Journal of Pharmacology and Experimental Therapeutics 258, 652-662.
40. YATANI, A., HAMILTON, A. S. & BROWN, A. M. (1986). Diphenylhydantoin blocks cardiac calcium channels and binds to the dihydropyridine receptor. Circulation Research 59, 356-361.